Evaluation of the Immunogenicity of an Inactivated Vaccine against the Adenovirus Egg Drop Syndrome 1976 in Poultry
Current Microbiology · 2026-08 · 83 (8)
DOI: 10.1007/s00284-026-05029-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, online erschienen am 30.06.2026. Verfasst von Mahmoud Ali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Egyptian Company for Biological & Pharmaceutical Industries (Vaccine Valley), 6th October City, Giza, 12511, Egypt. Hauptthemen laut MEDLINE: Poultry Diseases, Adenoviridae Infections, Atadenovirus, Viral Vaccines. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Egyptian Company for Biological & Pharmaceutical Industries (Vaccine Valley),.
Abstract (Originalsprache)
Egg Drop Syndrome 1976 (EDS-76) causes significant economic losses in Egyptian poultry. This study aimed to develop a safe and effective vaccine prepared from locally isolated and characterized EDS virus using mineral oil as adjuvants. The virus was propagated in duck embryos, achieving high hemagglutination unit (HAU) titers (15 log₂ HAU) and 50% embryo infectious (EID₅₀) titers (8.1 log₁₀ EID₅₀ /mL). The virus was successfully inactivated with 0.2% formalin. The virus antigen was formulated into oil-emulsion vaccines (250-2000 HAU per dose). In SPF chickens, the EDS hemagglutination inhibition (HI) and serum neutralization (SNT) tests were used to determine antibody levels. The results of HI and SNT showed that the vaccine induced rapid and robust immunity, with 100% seroconversion by week two. The highest dose (2000 HAU) elicited superior hemagglutination inhibition (HI; 13.5 ± 0.6 log₂) and virus neutralizing (12.0 ± 0.5 log₂) antibody titers by week four compared to a commercial vaccine. Furthermore, our results showed a strong correlation (R²=0.98) between HI and neutralization tests. These findings demonstrate that the local Egyptian EDS-76 virus is an ideal isolate for vaccine production, providing a promising and cost-effective tool for the effective control of EDS-76 in the Egyptian poultry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Egyptian Company for Biological & Pharmaceutical Industries (Vaccine Valley), 6th October City, Giza, 12511, Egypt.
- Egyptian Company for Biological & Pharmaceutical Industries (Vaccine Valley), 6th October City, Giza, 12511, Egypt. mn.shaheen@nrc.sci.eg.
- Virology Laboratory, Environment and Climate Change Institute, National Research Centre, Dokki, Giza, 12618, Egypt. mn.shaheen@nrc.sci.eg.
- Department of Virology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
- Department of Microbiology, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.
Förderung
- Egyptian Company for Biological & Pharmaceutical Industries (Vaccine Valley),
Zitieren
APA
Ali, M., El-Nagar, M. A., Shaheen, M. N. F., El-Sanousi, A. A., & Khalil, S. A. (2026). Evaluation of the Immunogenicity of an Inactivated Vaccine against the Adenovirus Egg Drop Syndrome 1976 in Poultry. Current Microbiology, 83(8). https://doi.org/10.1007/s00284-026-05029-3
Vancouver
Ali M, El-Nagar MA, Shaheen MNF, El-Sanousi AA, Khalil SA. Evaluation of the Immunogenicity of an Inactivated Vaccine against the Adenovirus Egg Drop Syndrome 1976 in Poultry. Current Microbiology. 2026;83(8). doi:10.1007/s00284-026-05029-3
BibTeX
@article{Ali2026,
author = {Ali, Mahmoud and El-Nagar, Mayar A and Shaheen, Mohamed Nasr Fathi and El-Sanousi, Ahmed A and Khalil, Samy A},
title = {Evaluation of the Immunogenicity of an Inactivated Vaccine against the Adenovirus Egg Drop Syndrome 1976 in Poultry},
journal = {Current Microbiology},
year = {2026},
volume = {83},
number = {8},
doi = {10.1007/s00284-026-05029-3}
}
EUVIMED